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Abstract
The orexigenic gut-brain peptide, ghrelin and its G-protein coupled receptor, the growth hormone secretagogue receptor
1a (GHS-R1A) are pivotal regulators of hypothalamic feeding centers and reward processing neuronal circuits of the brain.
These systems operate in a cooperative manner and receive a wide array of neuronal hormone/transmitter messages and
metabolic signals. Functional magnetic resonance imaging was employed in the current study to map BOLD responses to
ghrelin in different brain regions with special reference on homeostatic and hedonic regulatory centers of energy balance.
Experimental groups involved male, ovariectomized female and ovariectomized estradiol-replaced rats. Putative modulation
of ghrelin signaling by endocannabinoids was also studied. Ghrelin-evoked effects were calculated as mean of the BOLD
responses 30 minutes after administration. In the male rat, ghrelin evoked a slowly decreasing BOLD response in all studied
regions of interest (ROI) within the limbic system. This effect was antagonized by pretreatment with GHS-R1A antagonist
JMV2959. The comparison of ghrelin effects in the presence or absence of JMV2959 in individual ROIs revealed significant
changes in the prefrontal cortex, nucleus accumbens of the telencephalon, and also within hypothalamic centers like the
lateral hypothalamus, ventromedial nucleus, paraventricular nucleus and suprachiasmatic nucleus. In the female rat, the
ghrelin effects were almost identical to those observed in males. Ovariectomy and chronic estradiol replacement had no
effect on the BOLD response. Inhibition of the endocannabinoid signaling by rimonabant significantly attenuated the
response of the nucleus accumbens and septum. In summary, ghrelin can modulate hypothalamic and mesolimbic
structures controlling energy balance in both sexes. The endocannabinoid signaling system contributes to the
manifestation of ghrelin’s BOLD effect in a region specific manner. In females, the estradiol milieu does not influence the
BOLD response to ghrelin.
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Introduction
The hunger signal ghrelin [1] is a potent orexigenic hormone
[2] that acts via its G-protein coupled receptor, GHS-R1A [3]
within the central nervous system. The expression of GHS-R1A
mRNA shows a discrete albeit wide distribution pattern within the
neuroaxis [4,5]. The preganglionic neurons of parasympathetic
centers in the brainstem, hypothalamic nuclei with longstanding
history of contribution to regulation of feeding and energy
expenditure, the hippocampal formation and the dopaminergic
mesostriatal and mesolimbic systems arising from the rostral
mesencephalon are primary targets of direct, receptor-mediated
signaling of ghrelin. The binding of radiolabeled ghrelin to
identical, GHS-R1A containing loci proves the expression and
functional capacity of the receptor protein [6]. In addition to the
stomach [7], which provides the major ghrelin supply for the
brain, the production of ghrelin in a discrete set of hypothalamic
neurons has also been shown [8]. Ghrelin-immunoreactive axons
have been detected in rodent [8,9] and post-mortem human [10]
brains.
Although ghrelin signaling regulates several systems and
modulates a wide array of physiological functions in the organism
[11,12], a special attention follows its role in the regulation of
feeding and energy expenditure [13–16]. Pioneer works have
elucidated that ghrelin targets the orexigenic neuropeptide Y/
agouti-related protein-synthesizing neuron population in the
medial aspect of the arcuate nucleus [1,8,17] that, in turn, relays
the orexigenic signal to other hypothalamic feeding centers
including the paraventricular nucleus and the lateral hypothala-
mus [18]. They can respond to the hunger signal and execute
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effector commands via the endocrine and autonomic systems.
These ghrelin-regulated mechanisms ensure the homeostatic
control over feeding and energy expenditure [19]. In more recent
years, an intriguing concept has emerged about the explicit role of
ghrelin in regulation of the reward system [20–24]. Pharmaco-
logical targeting of the laterodorsal tegmentum-ventral tegmental
area-mesolimbic system axis by GHS-R1A agonists and/or
antagonists has shown the involvement of ghrelin in shaping the
hedonic component in the control of energy balance [25]. Ghrelin
seems to increase the incentive value of rewarding foods
[23,26,27], alcohol [28] and abusing drugs [29,30]. It also triggers
the cascades of reward seeking behavior [31]. Antagonizing
ghrelin signaling centrally offers a challenging approach in the
fight against obesity, substance and eating disorders [28,32,33].
A fascinating finding has been that ghrelin modifies the activity
of targeted neurons [8,34] and modulates the incoming informa-
tion of their synaptic afferents. Molecular events downstream from
GHS-R1A have not been fully explored yet. A prevailing role has
been attributed to PI3K-Akt [35] and AMPK [36] signaling
mechanisms at cellular level. Recent studies have revealed that the
sirtuin 1/p53 pathway links GHS-R1A activation and AMPK
phosphorylation in the hypothalamus [37]. Besides PI3K-Akt and
AMPK, additional mechanisms are involved in ghrelin action
including the k-opioid pathway in the hypothalamus [38].
Furthermore, increasing number of evidence indicates that
GHS-R1A activation results in changes of endocannabinoid levels
in the target cell that, in turn, modify the synaptic input of
neuronal afferents via retrograde signaling [39]. Accordingly, CB1
receptors and intact retrograde endocannabinoid signaling mech-
anisms have been reported essential in the mediation of the
orexigenic action of ghrelin in the paraventricular nucleus of the
rat [39], and also in the modulation of firing by ghrelin in
gonadotropin-releasing hormone (GnRH) neurons of mice [40]. In
addition to the cooperation of ghrelin and endocannabinoid
signaling systems, the modulatory role of the gonadal hormone
17b-estradiol (E2) has also been raised. Males and females with
low E2 levels show a higher response to ghrelin in terms of food
intake and body weight gain compared to females with high E2
levels [41], although a recent study has demonstrated no difference
in food intake and the signaling pathway downstream to GHS-
R1A in response to ghrelin in the two sexes [42].
In the present study, we focused on mapping BOLD responses
evoked by ghrelin in the male and female rat brains and on
elucidation of the role of endocannabinoid and E2 signaling in the
process with special attention to brain centers controlling energy
balance.
Materials and Methods
Ethics Statement
All studies were carried out with permission from the Animal
Welfare Committee of the Institute of Experimental Medicine,
Hungarian Academy of Sciences (Permission Number: A5769-01)
and in accordance with the legal requirements of the European
Community (Decree 86/609/EEC). In all studies, animal exper-
imentation was conducted in accord with accepted standards of
animal care.
Reagents
Rat ghrelin was obtained from Tocris (Bristol, UK). Rimona-
bant was synthesized by the Synthetic Laboratory of Gedeon
Richter Plc (Budapest, Hungary). GHS-R1A antagonist JMV2959
was a kind gift from Aeterna Zentaris GmbH (Frankfurt,
Germany).
Animals
Male (n = 20) and female (n = 24) Wistar rats, weighing 240–260
and 170–190 g, respectively, were purchased from Harlan. Rats
were housed in light (12:12 light-dark cycle, lights on at 6am) and
temperature (2161uC) controlled environment, with free access to
standard food (sniff R/M+H Spezieldia¨ten GmbH D-59494 Soest)
and tap water. The females were surgically ovariectomized (OVX)
and half of them were replaced with E2 (OVX+E2) for 10 days as
described elsewhere [43]. The average weight of OVX controls
(n = 12) and E2 replaced animals (n = 11) was 219.2 g and 207.6 g,
respectively. The weight of OVX controls was significantly larger
(p = 0.031).
MRI Experiments
Functional MRI experiments were performed on a 9.4T ASZ
Varian MRI system with a free bore of 210 mm, containing a
120 mm inner size gradient coil (180 ms rise time). For excitation,
an actively RF-decoupled 2 channel volume coil system with inner
size 72 mm was used and a fix tuned receive-only phase array rat
brain coil located directly above the dorsal surface of the animal’s
head to maximize the signal to noise ratio.
Scout pictures were obtained in planes of coronal and sagittal in
order to set the anatomical and functional images. Anatomical
scans were acquired using gradient echo multi slice (GEMS)
sequence with a field of view, FOV 35635 mm, slice thickness
1 mm, gap 0.2 mm. Nine slices were received in interleaved order;
the scanner’s default coronal orientation was slightly changed to
get a standard anatomically coronal plane according to the Rat
Brain Atlas of Paxinos & Watson [44]. Echo time, TE= 3.83 ms,
repetition time, TR=200 ms, flip angle 45u, averages 3, dummy
scans 4, data matrix 1926192, total scan time 2 min.
An interleaved triple-shot gradient-echo echo planar imaging,
EPI sequence with compressed segments was used for T2*-
weighted MR images. TE= 10 ms, TR=3000 ms, flip angle 90u,
averages 1, dummy scans 4, data matrix 64664, 1000 repetitions.
FOV and slice parameters were the same as in the anatomical
setup.
Rats were anaesthetized with isoflurane (5% starting concen-
tration and then 1–1.5% during scanning) administered in
compressed air. For intravenous drug administration, a cannula
line was inserted and used during the scanning. The anesthetized
rat was transferred into the magnet. Body temperature was
monitored using a rectal probe and maintained at 37 6 1uC via a
thermostatically controlled air, flowed around the rat. The
ventilation was also controlled.
Experiments lasted for 50 min. After 16 min 40 sec (1000 sec)
baseline period 20 mg ghrelin was administered i.v. The automat-
ed drug administration was performed with an infusion pump
controlled by optical signals. GHS-R1 antagonist JMV2959
(6 mg/kg) and rimonabant (3 mg/kg) or were applied i.p. to
conscious animals as a pretreatment one hour prior to ghrelin
administration. One measurement was performed with each
animal. The results of each measurement were stored in the
scanner’s own file format which were converted to the widely used
nifti-format (Neuroimaging Informatics Technology Initiative)
using a Matlab script. More detailed technical information about
the MRI has been published earlier [45].
Data Analysis
Data analysis was performed as described previously [45]. In
brief, displacement was checked and measurements with higher
than one voxel movement were excluded. For creating t-maps in
the phMRI experiments, paired t-test was performed on each
voxel’s two time intervals (pre-injection baseline and post-
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injection) to evaluate the difference between the baseline signal
and post-injection signal. A t-value was ordered to every voxels
and voxels over the t value limit were highlighted. Region of
interest (ROI) analysis was performed using a Matlab script. ROIs
were determined according to the Rat Brain Atlas of Paxinos &
Watson [44]. Statistical significance of drug effect was evaluated
by multifactorial ANOVA followed by post-hoc Fisher test.
List of ROIs and Their Abbreviations
We analyzed the following areas: amygdala (Amyg), arcuate
nucleus (ARC), cerebellum (cb), dorsomedial nucleus (DMH),
hippocampus (Hipp), lateral hypothalamus (LH), lateral parabra-
chial nucleus (LPB), laterodorsal tegmental nucleus (LDTg),
nucleus accumbens (Acb), nucleus tractus solitarii (Sol), paraven-
tricular nucleus (PVN), parietal associative cortex (PAC), prefron-
tal cortex (PFC), septum (Sept), striatum (Str), substantia nigra
(SN), suprachiasmatic nucleus (SCN), temporal cortex (TC),
ventral tegmental area (VTA), ventromedial nucleus (VMH).
Results
BOLD Response to Ghrelin in Homeostatic and Hedonic
Brain Centers Regulating Energy Balance in the Male Rat
In the first line of the experiment, the effect of ghrelin (20 mg,
i.v.) was tested in either saline or GHS-R1A antagonist JMV2959
(6 mg/kg, i.p.) pretreated male rats. The applied dose of ghrelin
corresponds to 25 nM/kg, which induces a marked stimulatory
effect in plasma GH levels [46]. ROIs were divided into three
groups, each containing well-defined nuclei and anatomical areas
as follows: Group I. Reward processing neuronal assembly
including the ventral tegmental area, nucleus accumbens, the
prefrontal cortex, amygdala, septum and hippocampus. Repre-
sentative fMRI image showing the nucleus accumbens was
presented (Fig. 1). The temporal cortex and associative parietal
cortex were included as controls. Group II. Homeostatic feeding
centers of the hypothalamus were represented by the arcuate
nucleus, ventromedial nucleus, dorsomedial nucleus, paraventri-
cular nucleus, lateral hypothalamus and the circadian rhythm
generator suprachiasmatic nucleus. Group III. Brainstem areas
regulating hedonic and homeostatic mechanisms of energy
balance included the laterodorsal tegmental nucleus, lateral
parabrachial nucleus, nucleus tractus solitarii. In addition, we
analyzed the main components of the nigrostriatal projection, the
substantia nigra and the striatum, and also the 9–10th lobules of
cerebellum.
We found a widespread regional response to ghrelin in hedonic
and homeostatic centers. The evoked BOLD responses differed
from each other in the saline and JMV2959 pretreated groups
(Fig. 2). In general, ghrelin decreased the BOLD response in
several loci of the neuroaxis, while JMV2959 pretreatment
attenuated this effect (Fig. 3). In Group I, the prefrontal cortex
(Fig. 2A) and the nucleus accumbens (Fig. 2B) showed the highest
response to ghrelin, and also a powerful and significant
counteracting effect of JMV2959. Moderate effects of ghrelin
were observed in the ventral tegmental area, the hippocampus,
septum and the amygdala (Fig. 3). In these loci, the BOLD
response was not significant. In Group II, representing the main
hypothalamic feeding centers and their modulator systems, ghrelin
was also potent in decreasing the BOLD response. Among these
structures, the ventromedial nucleus (Fig. 2C), the lateral
hypothalamus (Fig. 2D), the paraventricular nucleus (Fig. 2E)
and the suprachiasmatic nucleus (Fig. 2F) demonstrated significant
BOLD responses. The primary feeding center of the hypothala-
mus, the arcuate nucleus also displayed a marked response to
ghrelin which was attenuated with the antagonist pretreatment
(Fig. 3). In Group III, the laterodorsal tegmental nucleus, the
lateral parabrachial nucleus, the nucleus tractus solitarii showed
weak, non-significant BOLD responses (Fig. 3). A similar
activation pattern characterized the additionally examined regions
like the striatum, the parietal, temporal cortices and the cerebellar
cortex (Fig. 3).
Role of Sex and Estradiol in the Ghrelin-Evoked BOLD
Response
In addition to the male, fMRI studies have also been carried out
in chronically ovariectomized (OVX) and ovariectomized E2
replaced (OVX+E2) female rats in order to reveal the putative role
of sex and the actual E2 milieu in the generation of the BOLD
response evoked by ghrelin. The examined sets of ROIs were
similar to those used in the male rat experiment. Ghrelin resulted
in a decrease of the BOLD response in all ROIs both in the OVX
(n= 7) and OVX+E2 (n= 7) groups. The characteristics of the
response (slope, duration, maximal effect) were almost identical in
Figure 1. Characteristic fMRI BOLD response to ghrelin in the nucleus accumbens. a. Position of the nucleus accumbens (highlighted in
red) is shown in a horizontal scheme of the rat brain [44]. b. Ghrelin evoked a negative BOLD response in the nucleus accumbens. Slice thickness is
1 mm.
doi:10.1371/journal.pone.0097651.g001
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Figure 2. Mean of time response curves of ghrelin’s effect on BOLD responses in the prefrontal cortex (A), nucleus accumbens (B),
ventromedial nucleus (C), lateral hypothalamus (D), paraventricular nucleus (E) and suprachiasmatic nucleus (F). Blue and red colors
indicate pretreatment with saline and GHS-R1A antagonist (JMV2959), respectively. Arrows mark ghrelin (GHR) administration, which started at BOLD
response number 333 and lasted to 383 (999–1149 s). For quantifying drug effect, mean of the BOLD responses from 901 to 950 was calculated
(2703–2850 s). N = 5–7.
doi:10.1371/journal.pone.0097651.g002
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males and females as exemplified in the prefrontal cortex (Fig. 4A),
nucleus accumbens (Fig. 4B), ventromedial nucleus (Fig. 4C) and
the paraventricular nucleus (Fig. 4D). Seemingly, neither sex nor
E2 replacement in OVX females had impact on the ghrelin-
evoked BOLD responses in hedonic and homeostatic centers of
energy balance.
Effect of Rimonabant on the BOLD Response to Ghrelin
The effect of CB1 receptor antagonist rimonabant (3 mg/kg,
i.p.) was tested on the ghrelin response in the third experimental
line of the study. The effect of rimonabant was evaluated in
various areas by comparing BOLD responses to ghrelin in vehicle
(n = 5–7) and rimonabant (n = 7) pretreated animals. Rimonabant
highly and significantly attenuated the response to ghrelin in the
nucleus accumbens (Fig. 5A) and septum (Fig. 5B). In other ROIs,
rimonabant pretreatment did not interfere with the ghrelin-evoked
BOLD response in a statistically significant manner (Fig. 6).
Discussion
In this study, we explored the BOLD effects of peripherally
administered ghrelin in hedonic and homeostatic centers regulat-
ing energy balance in the rat using fMRI. Ghrelin administered to
the periphery can act on the brain directly [22,47], or indirectly
via vagal afferent [48]. We found a significant BOLD decrease in
response to ghrelin in homeostatic feeding centers of the
hypothalamus including the ventromedial nucleus, the paraven-
tricular nucleus and the lateral hypothalamic area by comparing
the saline and GHS-R1A antagonist pretreated animal groups.
Similar significant responses were measured in reward signal
processing structures of the telencephalon like the prefrontal
cortex, the nucleus accumbens and the septum. These findings are
in agreement with recent fMRI studies demonstrating ghrelin-
evoked modulation of the brain reinforcement system [49] and key
appetite regulatory regions of the hypothalamus [50] in rodents. In
addition to the male, we also followed the BOLD response to
ghrelin in females, using low (ovariectomized) and high (ovariec-
tomized-E2 replaced) experimental E2 paradigms. The results do
not support any sex difference in the ghrelin-evoked BOLD
responses or the regulation of the response by the female gonadal
hormone, E2. We note that in the male-female comparison we
used OVX females with/without E2 replacement and compared
them to intact males. For revealing the putative contribution of the
endocannabinoid signaling mechanism to the ghrelin-evoked
BOLD response, we also examined the effects of ghrelin
administration in CB1 receptor blocked male rats and found
interaction between the two signaling systems in telencephalic
structures. From the results we conclude that i) ghrelin regulates
components of the classic mesolimbic reward system, especially the
prefrontal cortex, the nucleus accumbens and the septum; ii)
ghrelin acts in key hypothalamic feeding centers, the ventromedial
nucleus, the paraventricular nucleus and the lateral hypothalamic
area; iii) the pattern of BOLD response to ghrelin resembles partly
the published expression loci of GHS-R1A mRNA; iv) the effect of
ghrelin on BOLD response depends on CB1 signaling in the
nucleus accumbens and the septum; and v) ghrelin-evoked BOLD
response is independent of sex and the actual E2 milieu.
Ghrelin Modulates the BOLD Response of Reward Signal
Processing Systems
The ventral tegmental area is a key center in reward processing
[51]. It contains the A10 dopaminergic cell group [52] that gives
rise to ascending mesocortical and mesolimbic projections that
innervate the prefrontal cortex and the nucleus accumbens,
respectively [53]. GHS-R1A mRNA has been detected within A10
dopaminergic neurons and cholecystokinin-immunoreactive neu-
rons of the VTA [4]. Ghrelin regulates dopaminergic neurons in
the VTA [54]. Via modulation of the mesolimbic dopaminergic
system, ghrelin is capable of increasing food intake [14,21,23],
modulating hedonic reward value of food, alcohol and addictive
chemical substances [22], regulating hyperlocomotion caused by
psychostimulant drugs [29,55] and increasing effectiveness of
learning and memory [56–58]. Our present findings are in concert
with these physiological data by demonstrating that peripheral
ghrelin administration causes marked alterations of the BOLD
Figure 3. Effect of ghrelin on BOLD responses in reward processing centers, hypothalamic nuclei, brainstem and control areas of
the rat brain. The effect of ghrelin after vehicle pretreatment is represented by blue columns and after JMV2959 pretreatment in red columns.
Statistically significant differences were found in the prefrontal cortex (PFC), nucleus accumbens (Acb), lateral hypothalamus (LH), paraventricular
nucleus (PVN), ventromedial nucleus (VMH) and suprachiasmatic nucleus (SCN). ANOVA and Fisher post hoc test *: p,0.05; **: p,0.01. N= 5–7.
doi:10.1371/journal.pone.0097651.g003
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response in different structural constituents of the mesolimbic and
mesocortical systems. Most notably, it modifies the BOLD
response of the nucleus accumbens and prefrontal cortex in a
significant manner. The effectiveness of JVM2959 treatment
strengthens the view that the manifestation of the ghrelin-evoked
BOLD response requires the contribution of GHS-R1A. The
facilitative role of GHS-R1A in the regulation of the brain
reinforcement system has recently been proposed in the rat based
on pharmacological MRI analysis and intracranial self-stimulation
[49]. Ghrelin increased the cerebral blood volume (rCBV) in
medial and lateral hypothalamic structures and also in mesolimbic
reward units, the ventral tegmental area, the nucleus accumbens
and septum. The responsiveness of hypothalamic feeding nuclei to
ghrelin has also been published in mice using manganase-
enhanced MRI [50].
Ghrelin Changes the BOLD Response of Homeostatic
Feeding Centers in the Hypothalamus
GHS-R1A is extensively expressed in the rodent hypothalamus
[3–5,59,60]. In concert with the distribution pattern of GHS-R1
mRNA expression, we report matching BOLD response from the
ventromedial nucleus, the paraventricular nucleus and the lateral
hypothalamus. The evoked BOLD effects were attenuated by
JMV2959. The arcuate nucleus did also respond to ghrelin, but
the effect did not reach statistical significance. The orexigenic
effects of ghrelin involve and require AMPK signaling in both the
VMH [61] and the PVN [39,62]. In the lateral hypothalamic area,
ghrelin evokes Fos immunoreactivity in orexin neurons [63] and
also inhibits their electrophysiological activity [9]. Binding of
iodinated ghrelin ligand has been reported [6] in all feeding
centers of the hypothalamus that showed BOLD response to
ghrelin challenge in our study.
Figure 4. Mean of time response curves of ghrelin’s effect on the BOLD responses in the prefrontal cortex (A), nucleus accumbens
(B), ventromedial nucleus (C) and paraventricular nucleus (D), in males (blue), ovariectomized females (orange) and
ovariectomized females treated with E2 (green). Arrows mark ghrelin administration, which started at BOLD response 333 and lasted to
383 (999–1149 s). For quantifying drug effect mean of the BOLD responses from 901 to 950 was calculated (2703–2850 s). N = 11–14.
doi:10.1371/journal.pone.0097651.g004
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Pharmacological Blocking of CB1 Signaling Attenuates
the Ghrelin-Evoked BOLD Response
Both ghrelin and endocannabinoids regulate energy balance
[64,65]. The ghrelin and endocannabinoid signaling mechanisms
are interrelated in the hypothalamus. Blocking CB1 receptor by
specific antagonists abolishes the orexigenic effect of ghrelin [66].
Ghrelin is also incapable of triggering orexigenic effects in CB1-
knockout mice [39]. Activation of GHS-R has been shown to
increase the endocannabinoid content of the hypothalamus [39].
Ghrelin inhibits the excitatory inputs to parvocellular paraven-
tricular neurons [39] and gonadotropin-releasing hormone
(GnRH) neurons [40] via the cooperation with the endocannabi-
noid-CB1 system. While the individual regulatory capacity of both
the endocannabinoid and ghrelin systems has been confirmed in
other parts of the brain as well [67–69], the coupled nature of
these signaling mechanisms awaits further studies and clarification.
In our fMRI study, the pharmacological inhibition of CB1 by
rimonabant abolished the BOLD response to ghrelin in the
nucleus accumbens and the septum. This result is in concert with
the finding that 2-arachidonoylglycerol signaling through CB1
regulates the activity of forebrain neural circuits that control
energy expenditure [70]. The BOLD response of the hippocampus
to ghrelin was only partially attenuated by rimonabant. In
individual hypothalamic nuclei, the blockade of CB1 receptor
did not counteract the BOLD effects of ghrelin. Seemingly, this
finding is in conflict with physiological data exploring the coupled
nature of ghrelin and endocannabinoid signaling mechanisms. It
needs further studies, although, it is also possible that the current
resolution power of the used fMRI technology does not allow the
Figure 5. Mean of time response curves of ghrelin’s effect on BOLD responses in the nucleus accumbens (A) and septum (B) after
vehiculum (blue) or rimonabant pretreatment (red). Arrows mark ghrelin administration, which started at BOLD response 333 and lasted to
383 (999–1149 s). For quantifying drug effect, mean of the BOLD responses from 901 to 950 was calculated (2703–2850 s). N = 5–7.
doi:10.1371/journal.pone.0097651.g005
Figure 6. Effect of ghrelin on BOLD responses in reward processing centers, hypothalamic nuclei and brainstem areas. Effect of
ghrelin on the BOLD responses was represented by the blue columns after vehicle pretreatment, and red columns after rimonabant pretreatment.
Statistically significant differences were found in the nucleus accumbens and septum. ANOVA and Fisher post hoc test. *: p,0.05. N = 5–7.
doi:10.1371/journal.pone.0097651.g006
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imaging of this particular molecular interaction in small-sized
hypothalamic nuclei.
Correlating Human and Rodent fMRI Data about the
Central Effects of Ghrelin
The current data and the previously reported fMRI results
[49,50] on actions of ghrelin in the CNS are in consensus and
suggest that ghrelin exerts the most potent effects on the
mesolimbic reward system (VTA, Acb, PFC, Sept) and hypotha-
lamic centers engaged to regulation of feeding and energy
expenditure (ARC, VMH, PVN, LH, SCN). Therefore, in
rodents, fMRI offers a unique and powerful tool for the
exploration of neuronal centers serving the hedonic and homeo-
static components of feeding under the challenge of orexigenic and
anorexigenic hormones. In humans, ghrelin was reported to
modulate the activity of brain regions involved in the control of
appetitive behavior [71]. BOLD changes characterized visual
information processing centers (occipital gyrus, fusiform gyrus), the
insula, as the main gustatory center and limbic structures
(substantia nigra, striatum, orbitofrontal cortex, amygdala, cau-
date and hippocampus) involved in appetite behavior. Fasting
levels of ghrelin also correlate with the brain response to pictures
of palatable food, with activation of visual, gustatory, limbic
reward and hypothalamic centers [72]. A bolus injection of ghrelin
in the postprandial period decreases the BOLD response of several
brain regions known to control appetite and feeding in humans
and it inhibits the response of the CNS to ingested lipid [73]. In
the latter study, the response remained essentially unchanged after
entering the covariates of body mass index and sex. Our study,
also favors the lack of sex specificity of ghrelin action in the rodent
brain.
In summary, the present study revealed that ghrelin evokes a
marked response in the rodent brain and modulates both the
hedonic and homeostatic components of feeding regulating
neuronal assemblies. The generated response is not sex specific
and the manifestation of ghrelin’s effect depends on endocanna-
binoid signaling in main reward signal processing centers.
Furthermore, at the level of CNS, the responses to ghrelin are
remarkably similar in humans and rats.
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